Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
European Journal of Cancer (Oxford, England : 1990)
|
May 31, 2016
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
Lawrence H Schwartz, Lesley Seymour, Saskia Litière, et al.
Neuro-Oncology
|
January 23, 2019
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
Adrienne Boire, Dieta Brandsma, Priscilla K Brastianos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2012
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
Matthias Preusser, Frank Winkler, Laurence Collette, et al.
JCO Clinical Cancer Informatics
|
November 21, 2025
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
Daniel Kates-Harbeck, Hans Kreipe, Oleg Gluz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 19, 2016
RECIST 1.1-Update and clarification: From the RECIST committee
Lawrence H Schwartz, Saskia Litière, Elisabeth de Vries, et al.
Cancer Treatment Reviews
|
February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel
Minetta C Liu, George D Demetri, Donald A Berry, et al.
Journal of Neuro-Oncology
|
March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Nature Medicine
|
October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtyping
Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
European Journal of Cancer (Oxford, England : 1990)
|
May 31, 2016
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
Lawrence H Schwartz, Lesley Seymour, Saskia Litière, et al.
Neuro-Oncology
|
January 23, 2019
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
Adrienne Boire, Dieta Brandsma, Priscilla K Brastianos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2012
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
Matthias Preusser, Frank Winkler, Laurence Collette, et al.
JCO Clinical Cancer Informatics
|
November 21, 2025
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
Daniel Kates-Harbeck, Hans Kreipe, Oleg Gluz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 19, 2016
RECIST 1.1-Update and clarification: From the RECIST committee
Lawrence H Schwartz, Saskia Litière, Elisabeth de Vries, et al.
Cancer Treatment Reviews
|
February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel
Minetta C Liu, George D Demetri, Donald A Berry, et al.
Journal of Neuro-Oncology
|
March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Nature Medicine
|
October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtyping
Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Page
of 4